| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Pier Giovanni Baraldi | |
| Romeo Romagnoli | |||
| Katia Varani | |||
| Pier Andrea Borea | |||
| Allan R Moorman | |||
| P2860 | cites work | Regulation of G protein-coupled receptors by allosteric ligands | Q26864384 |
| Synthesis and biological evaluation of novel allosteric enhancers of the A1 adenosine receptor based on 2-amino-3-(4'-chlorobenzoyl)-4-substituted-5-arylethynyl thiophene | Q28247159 | ||
| Emerging adenosine receptor agonists | Q28249111 | ||
| Adenosine receptors as drug targets--what are the challenges? | Q29346491 | ||
| 2-Aminothiazoles: a new class of agonist allosteric enhancers of A(1) adenosine receptors | Q30309409 | ||
| The second extracellular loop of the adenosine A1 receptor mediates activity of allosteric enhancers | Q30408394 | ||
| 2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists. | Q30439856 | ||
| The allosteric enhancer, PD 81,723, stabilizes human A1 adenosine receptor coupling to G proteins | Q30465454 | ||
| Allosteric binding sites on cell-surface receptors: novel targets for drug discovery | Q34139176 | ||
| Pharmacology and therapeutic applications of A1 adenosine receptor ligands | Q34175454 | ||
| Allosteric modulation of G protein-coupled receptors. | Q34336467 | ||
| International Union of Basic and Clinical Pharmacology. XC. multisite pharmacology: recommendations for the nomenclature of receptor allosterism and allosteric ligands. | Q34429173 | ||
| G protein-coupled receptor allosterism and complexing | Q34523552 | ||
| Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? | Q34581080 | ||
| International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update | Q34701303 | ||
| Signalling from adenosine receptors to mitogen-activated protein kinases | Q35166514 | ||
| Allosteric modulation of purine and pyrimidine receptors | Q35190426 | ||
| A Monod-Wyman-Changeux mechanism can explain G protein-coupled receptor (GPCR) allosteric modulation | Q35643821 | ||
| Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery | Q35952381 | ||
| Allosteric modulation of the adenosine family of receptors | Q36172721 | ||
| A pharmacological organization of G protein-coupled receptors | Q36575957 | ||
| Allosteric enhancers for A1 adenosine receptor | Q36855834 | ||
| Allosteric modulation of heterodimeric G-protein-coupled receptors. | Q37005570 | ||
| Allosteric modulation of adenosine receptors | Q37211873 | ||
| Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders | Q37360436 | ||
| Adenosine receptors and neurological disease: neuroprotection and neurodegeneration | Q37565211 | ||
| '7TM receptor allostery: putting numbers to shapeshifting proteins | Q37591623 | ||
| Adenosine receptors as drug targets | Q37691817 | ||
| Allosteric modulation of adenosine receptors | Q37769801 | ||
| Allosteric Enhancers of A1 Adenosine Receptors: State of the Art and New Horizons for Drug Development | Q37782368 | ||
| Adenosine and related drugs in brain diseases: present and future in clinical trials | Q37852724 | ||
| Introductory overview of purinergic signalling | Q37881552 | ||
| Cardiovascular adenosine receptors: expression, actions and interactions | Q38114251 | ||
| Purinergic signalling: pathophysiology and therapeutic potential | Q38143501 | ||
| Synthesis and biological evaluation of 2,3,5-substituted [1,2,4]thiadiazoles as allosteric modulators of adenosine receptors | Q40597031 | ||
| An allosteric modulator of the adenosine A1 receptor improves cardiac function following ischaemia in murine isolated hearts. | Q42922738 | ||
| Enhancer and competitive allosteric modulation model for G-protein-coupled receptors | Q42923809 | ||
| Delineating the mode of action of adenosine A1 receptor allosteric modulators | Q43023574 | ||
| Hybrid ortho/allosteric ligands for the adenosine A(1) receptor | Q43117671 | ||
| 2-Amino-3-aroyl-4,5-alkylthiophenes: agonist allosteric enhancers at human A(1) adenosine receptors | Q43849719 | ||
| Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain | Q44006934 | ||
| Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A₁ adenosine receptor | Q44013005 | ||
| Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor | Q44320313 | ||
| Allosteric adenosine receptor modulation reduces hypersensitivity following peripheral inflammation by a central mechanism | Q44329135 | ||
| 2-Amino-3-benzoylthiophene Allosteric Enhancers of A1 Adenosine Agonist Binding: New 3, 4-, and 5-Modifications | Q44424784 | ||
| Synthesis of 2-amino-3-heteroaroylthiophenes and evaluation of their activity as potential allosteric enhancers at the human A1 receptor | Q45089741 | ||
| Allosteric modulators of the adenosine A1 receptor: synthesis and pharmacological evaluation of 4-substituted 2-amino-3-benzoylthiophenes. | Q45974813 | ||
| Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N-(substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor | Q46409470 | ||
| Allosteric modulation of adenosine A1 receptor coupling to G-proteins in brain | Q46442475 | ||
| 2-Aminothiophene-3-carboxylates and carboxamides as adenosine A1 receptor allosteric enhancers | Q46824835 | ||
| 5-Substituted 2-aminothiophenes as A1 adenosine receptor allosteric enhancers | Q46916256 | ||
| Synthesis and biological effects of novel 2-amino-3-(4-chlorobenzoyl)-4-substituted thiophenes as allosteric enhancers of the A1 adenosine receptor. | Q47868551 | ||
| Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding | Q48117393 | ||
| TRR469, a potent A(1) adenosine receptor allosteric modulator, exhibits anti-nociceptive properties in acute and neuropathic pain models in mice. | Q51750289 | ||
| Synthesis and characterization of novel 2-amino-3-benzoylthiophene derivatives as biased allosteric agonists and modulators of the adenosine A(1) receptor. | Q51761046 | ||
| Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A₁ adenosine rece | Q51762827 | ||
| The synthesis and biological evaluation of 2-amino-4,5,6,7,8,9-hexahydrocycloocta[b]thiophenes as allosteric modulators of the A1 adenosine receptor. | Q51767664 | ||
| Allosteric Modulation of G Protein–Coupled Receptors | Q56115675 | ||
| Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor Ligands | Q57838214 | ||
| Synthesis and Biological Evaluation of 2-Amino-3-(4-chlorobenzoyl)-4-[(4-arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-Modification on Allosteric Enhancer Activity at the A1 Adenosine Receptor | Q59171571 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1247-1259 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Future Medicinal Chemistry | Q19280078 |
| P1476 | title | Current status of A1 adenosine receptor allosteric enhancers | |
| P478 | volume | 7 |
| Q48732639 | Biochemical and Pharmacological Role of A1 Adenosine Receptors and Their Modulation as Novel Therapeutic Strategy. |
| Q39341570 | Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity. |
| Q33707895 | The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors, SB269652 May Lead to a New Generation of Antipsychotic Drugs |
Search more.